Dose escalation with simultaneous integrated boost for un-methylated multiple glioblastoma.

These advantages may be significant in patients with ‘multiple gliomas’ whose aggressive tumors may have a more pronounced accelerated tumor cell repopulation.

also in 13,097 other papers